• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[所有人工瓣膜患者都应该接受抗血小板药物治疗吗?]

[Should all prosthetic valve patients be treated by platelet inhibitors?].

作者信息

Lévy G, Bordes F, Mariottini P, François G

出版信息

Nouv Presse Med. 1976 Jan 31;5(5):251-4.

PMID:1264682
Abstract

The number, volume and adhesive and aggregation activities of platelets were studied in 31 patients with artificial valves. The differences observed in comparison with a control population are due to stimulation of thrombocytopoiesis secondary to the destruction or concumption of the platelets, it being impossible to be sure as to the dominant mechanism. Under these circumstances it would seem important in each patient to verify the therapeutic effectiveness of platelet inhibitors or of traditionnal anticoagulants by direct or indirect study of platelet life duration.

摘要

对31例人工瓣膜患者的血小板数量、体积以及黏附与聚集活性进行了研究。与对照组相比所观察到的差异是由于血小板破坏或消耗继发的血小板生成刺激所致,目前尚无法确定主要机制。在这种情况下,通过直接或间接研究血小板寿命来验证血小板抑制剂或传统抗凝剂对每位患者的治疗效果似乎很重要。

相似文献

1
[Should all prosthetic valve patients be treated by platelet inhibitors?].[所有人工瓣膜患者都应该接受抗血小板药物治疗吗?]
Nouv Presse Med. 1976 Jan 31;5(5):251-4.
2
Reduction of platelet activity in patients with prosthetic heart valves.人工心脏瓣膜患者血小板活性的降低
Rev Med Brux. 1980 Feb;1(2):71-5.
3
[Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].[人工心脏瓣膜患者的抗凝与血小板抑制治疗]
Orv Hetil. 1987 Feb 1;128(5):239-42.
4
Preventing thromboembolism in patients with prosthetic heart valves.预防人工心脏瓣膜患者的血栓栓塞
Cardiol Clin. 1994 Aug;12(3):487-93.
5
[Evaluation of antiplatelet drug therapy and replaced heart valves based on platelet functions].基于血小板功能的抗血小板药物治疗与置换心脏瓣膜评估
Kyobu Geka. 1983 Sep;36(9):701-5.
6
[Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].[妊娠、心脏瓣膜假体与抗血小板聚集治疗]
Nouv Presse Med. 1975 Mar 8;4(10):746 (2).
7
Platelet survival and function in animals with prosthetic mitral valve: the effect of nafazatrom.人工二尖瓣动物模型中血小板的存活与功能:萘呋胺酯的作用
Thromb Haemost. 1984 Oct 31;52(2):99-101.
8
[Thromboembolism prevention after heart valve prosthesis in an experimental model].[实验模型中心脏瓣膜置换术后的血栓栓塞预防]
Thoraxchir Vask Chir. 1972 Dec;20(6):419-23. doi: 10.1055/s-0028-1099034.
9
Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
Eur Heart J. 2007 Oct;28(20):2552-3; author reply 2553-4. doi: 10.1093/eurheartj/ehm353. Epub 2007 Sep 6.
10
[Anticoagulants in therapy of patients with heart valve prostheses].[抗凝剂在心脏瓣膜置换患者治疗中的应用]
Minerva Med. 1975 Apr 4;66(25):1229-35.